The recruitment rate describes the speed at which study participants are enrolled into a clinical trial. It is typically expressed as the number of patients enrolled per month or per site per month. A realistic estimate of the recruitment rate is a key component of study planning, as it directly affects the overall study duration, budget calculations, and timeline adherence. <\/p>\n
The recruitment rate is calculated as the number of enrolled patients divided by the number of active study months and active sites. In practice, it is often reported as a monthly rate per site to ensure comparability across studies of different sizes. For example, a study planned to run for 24 months and requiring 300 patients would, with 10 active sites, require an average rate of 1.25 patients per site per month. <\/p>\n
Numerous factors influence the actual recruitment rate: the prevalence and incidence of the target disease, the stringency of the inclusion and exclusion criteria (eligibility criteria), the experience and capacity of the investigational sites, the quality of patient information and the informed consent process, as well as external factors such as seasonal fluctuations, competing studies, and pandemic-related interruptions. The length and complexity of the informed consent process and the number of study visits also affect whether potential participants agree to take part. A comprehensive site feasibility assessment prior to study start is therefore indispensable. <\/p>\n
A realistic estimate of the recruitment rate begins with the feasibility study. Sites are assessed based on their patient population, their experience in the indication area, and their capacity. Historical recruitment data from previous studies, database queries (e.g., screening registries), and surveys of investigators provide the basis for the forecast. <\/p>\n
The study protocol and the Clinical Trial Agreement (CTA) define recruitment targets per site and time period. These targets feed into the study milestones\u2014particularly First Patient First Visit (FPFV) and Last Patient First Visit (LPFV). CROs such as mediconomics rely on systematic data analysis and benchmarking from comparable studies in recruitment planning to identify sites with the highest recruitment potential. <\/p>\n
The actual recruitment rate is regularly monitored during the study through clinical monitoring and project management. Dashboards and central monitoring systems display cumulative recruitment compared with the plan. Deviations of more than 20\u201330% over two consecutive months are typically considered an escalation threshold and trigger a recruitment recovery discussion with the affected site. <\/p>\n
Measures to improve the recruitment rate include targeted patient recruitment campaigns (e.g., digital advertising, physician mailings), activation of additional sites, relaxation of eligibility criteria via protocol amendment, and the use of patient recruitment service providers. In multicentre international studies, geographic reallocation of patient numbers between countries can safeguard overall recruitment. <\/p>\n
The planned recruitment rate and actual recruitment performance are documented in several regulatory documents. The study protocol includes the recruitment plan with assumptions regarding the recruitment rate. The Clinical Study Report (CSR) in accordance with ICH E3 includes a dedicated section on patient recruitment that compares planned and actual recruitment curves. <\/p>\n
Sponsors are required to update recruitment status regularly in the Clinical Trials Information System (CTIS). Delays that lead to protocol amendments or extensions of the approval period must be reported to the competent authorities and ethics committees. GCP inspections verify whether the documented recruitment figures match the actual source data. <\/p>\n
A low recruitment rate is one of the most common reasons for study delays and discontinuations in clinical research. Studies show that a large proportion of clinical trials exceed the planned recruitment period, resulting in significant cost increases. Early identification of risks through risk-based monitoring and proactive site management by project management are therefore critical to study success. <\/p>\n
For full-service CROs, the recruitment rate is of particular importance because it directly affects budget planning, resource allocation, and contracting with sites. Realistic recruitment-rate assumptions in the feasibility phase and consistent monitoring during the study are core competencies of experienced CRO project management. <\/p>\n
What is a typical recruitment rate in clinical trials?<\/strong><\/p>\n There is no universal benchmark, as the recruitment rate depends heavily on the indication area, study design, and eligibility criteria. In oncology studies with strict inclusion criteria, rates of 0.3\u20130.5 patients per site per month may be normal, whereas in studies of common diseases, rates of 2\u20135 patients per site per month are realistic. The feasibility study should use historical data from the respective indication as a reference. <\/p>\n How is a poor recruitment rate addressed?<\/strong><\/p>\n If the planned recruitment rate is significantly missed, several measures are available: activation of additional sites, expansion of eligibility criteria via protocol amendment, targeted patient recruitment campaigns, intensified site coaching by the Clinical Research Associate (CRA), and the use of specialised patient recruitment service providers. Early escalation is crucial before delays become unmanageable. <\/p>\n What role does the recruitment rate play in power calculations?<\/strong><\/p>\n The recruitment rate directly affects study duration, but not statistical power per se\u2014power depends on the sample size. If the planned sample size is not achieved due to an overly low recruitment rate, the study\u2019s power decreases and the risk of a type II error increases. In studies with an adaptive design, an adjustment of the sample size (sample size re-estimation) based on an interim analysis can be planned if recruitment falls behind schedule. <\/p>\n","protected":false},"excerpt":{"rendered":" The recruitment rate describes the speed at which study participants are enrolled into a clinical trial. It is typically expressed as the number of patients enrolled per month or per site per month. A realistic estimate of the recruitment rate is a key component of study planning, as it directly affects the overall study duration, […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[],"class_list":["post-6752","glossary","type-glossary","status-publish","hentry"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6752\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=6752"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=6752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}